EB
Eastern Bankshares, Inc. (EBC)·Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 delivered a clean beat versus internal Q3 guidance: net interest income landed at $179.2M (guided $175–$180M), NIM (FTE) reached 3.05% (top of 3.00–3.05% guide), and operating noninterest income exceeded guide at $36.9M ($33–$34M) while operating noninterest expense was modestly above plan at $133.7M ($130–$132M) .
- GAAP diluted EPS was $0.30 and operating diluted EPS was $0.34, with margin expansion supported by lower deposit costs; cost of deposits fell to 1.69% (from 1.82% in Q3) .
- Management announced a $1.2B investment portfolio repositioning to be completed mid-Q1 2025, expected to add ~$0.13 to 2025 operating EPS,
18 bps to margin and improve ROA/ROTCE; the after-tax loss ($200M) is already reflected in equity . - Credit costs were elevated: annualized net charge-offs rose to 0.71%, driven primarily by investor office PCD loans acquired from Cambridge; non-performing loans increased to 0.76% of loans .
- FY2025 outlook: NII $815–$840M, full-year NIM (FTE) 3.45–3.55%, loan growth 2–4%, deposit growth 1–2%, provision $30–$40M, operating noninterest income $130–$140M, operating noninterest expense $535–$555M, tax rate 22–23% .
What Went Well and What Went Wrong
What Went Well
- Net interest margin expanded 8 bps to 3.05%, aided by deposit repricing; cost of deposits fell 13 bps to 1.69% compared to Q3 .
- Wealth management momentum: trust and advisory fees climbed to $18.0M (including $1.2M one-time), alongside a $9.3M non-operating gain on an equity investment (Numerated sale to Moody’s) .
- Strategic capital actions: $1.2B securities repositioning to add ~$0.13 to 2025 operating EPS and ~18 bps to margin; repurchased 908K shares in Q4 at $17.41 and an additional 761K in January; dividend $0.12 declared .
What Went Wrong
- Elevated credit costs in office CRE: net charge-offs increased to $31.7M (0.71% of average loans), mostly investor office PCD loans; NPLs rose to $135.8M (0.76% of loans) .
- Tangible book value per share declined sequentially to $11.98 (from $12.17), reflecting AOCI movements and merger-related dynamics .
- Operating noninterest expense rose linked-quarter to $133.7M (from $130.9M), as partial-quarter Cambridge impact in Q3 normalized and certain categories increased (e.g., data processing, amortization of intangibles) .
Financial Results
Segment/noninterest income breakdown ($USD Millions):
Key KPIs:
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Our margin expanded by 8 basis points, supported by a reduction in deposit costs.” – CFO David Rosato .
- “We are executing on a $1.2 billion repositioning... expected to be $0.13 accretive to operating EPS in 2025.” – CFO David Rosato .
- “Our most significant milestone was the merger with Cambridge Trust... solidifies our position as a leading financial institution in our region.” – Executive Chair Bob Rivers .
- “We posted full year operating net income of $192.6 million, 18% higher than 2023.” – CEO Denis Sheahan .
Q&A Highlights
- Portfolio repositioning earn-back: ~$200M loss for ~$35M annual NII benefit equates to ~5.7-year earn-back; driven by low-yield, longer-duration bonds sold; expected reinvestment yields ~4.75–5% .
- Margin timing: mid-Q1 execution implies partial benefit in Q1, full run-rate in Q2; December spot margin was 3.13%, normalized ~3.08% due to extra accretion .
- Office CRE specifics: ~81% of Q4 charge-offs tied to previously reserved credits; Q4 CRE charge-offs were essentially all office; criticized/classified investor office ended ~$184M; upcoming maturities largely accruing and expected to resolve without issues .
- Capital returns: 908K shares repurchased in Q4; 761K in January; ~8.3M shares remain under authorization through July .
- Loan growth outlook and market disruption: guidance (2–4% loan growth) excludes potential uplift from local mergers disrupting competitors; upside possible but not embedded in plan .
Estimates Context
- Wall Street consensus estimates from S&P Global were unavailable due to data access limits at time of retrieval; as a result, a direct comparison to consensus EPS and revenue could not be provided.
- Relative to internal Q3 guidance, Q4 results were strong: NII at $179.2M (near high end), NIM 3.05% (top end), operating noninterest income beat ($36.9M vs $33–$34M), and operating noninterest expense modestly above ($133.7M vs $130–$132M) .
Key Takeaways for Investors
- Margin tailwinds: Lower deposit costs (1.69% in Q4) and $1.2B portfolio repositioning should support NIM expansion through 2025; full-year NIM (FTE) guided to 3.45–3.55% .
- Credit watch but contained: Office CRE is the primary headwind; most Q4 charge-offs were previously reserved PCD loans; allowance coverage remains robust at 1.29% of loans and CET1 15.73% .
- Wealth growth and fee resilience: Wealth fees reached $18.0M with one-time uplift; fee reinstatement on Cambridge accounts adds incremental noninterest income .
- Capital deployment: Ongoing buybacks and maintained dividend ($0.12) signal confidence in capital strength and earnings trajectory .
- FY2025 setup: NII $815–$840M and NIM 3.45–3.55% imply material ROA/ROTCE improvement, even as provision normalizes ($30–$40M) .
- Tactical trading: Near-term catalysts include completion of repositioning, visible margin uplift, and clarity on office CRE resolutions; risks center on credit migration and rate path variability .
- Medium-term thesis: Enhanced earnings power post-merger, improving margin structure, diversified fee base (wealth), and conservative credit posture support compounding returns as rates ease and deposit betas normalize .